Latest filing published 06 Jun 2025 for Light & Wonder, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Dr Kneeland Youngblood: trading record in brief
Filings by Dr Kneeland Youngblood span 6 companies, the busiest being Starwood Hotel & Resorts Worldwide, Inc, Burger King Holdings Inc and Mallinckrodt plc. In total, 113 filings cover trades dated from 30 December 2005 to 5 June 2025.
Both buying and selling appear: 2 purchases worth €131k, against 27 sales worth €3.3M. Netting one side against the other leaves €3.2M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 54 share grants and 27 option exercises.
The newest entry dates from 6 June 2025: an option exercise, in Light & Wonder, Inc. The latest purchase dates back some time: it was published 3,265 days ago, on 30 November 2017. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dr Kneeland Youngblood
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,159 shares0Common StockSEC:0000950157-25-000476:0
- 2,093 shares0Common StockSEC:0000950157-24-000878:0
- 3,320 shares0Common StockSEC:0000950157-24-000863:0
- 40,004 sharesCommon Stock, par value $0.00001 per shareSEC:0000950170-24-016389:1
- 400,038 sharesCommon Stock, par value $0.0001 per shareSEC:0000950170-24-016389:0
- 400,038 sharesCommon Stock, par value $0.00001 per shareSEC:0000950170-24-007642:1
- 400,038 sharesCommon Stock, par value $0.0001 per shareSEC:0000950170-24-007642:0
- 1,928 shares0Common StockSEC:0000950157-23-000656:1
- 2,093 shares0Common StockSEC:0000950157-23-000656:0
- 3,840 shares0Common StockSEC:0000950157-23-000640:0
- 400,038 shares0Common StockSEC:0001209191-22-048849:0
- 1,927 shares0Common StockSEC:0000950157-22-000709:0
- 2,093 shares0Common StockSEC:0000950157-22-000691:1
- 2,763 shares0Common StockSEC:0000950157-22-000691:0
- 1,928 shares0Common StockSEC:0000950157-21-000657:0
- 2,093 shares0Common StockSEC:0000950157-21-000629:0
- 38,300 shares@ US$0.131615.2% of flowOrdinary SharesSEC:0000950138-20-000457:0
- 1,927 shares0Common StockSEC:0000750004-20-000089:0
- 8,729 shares@ US$2.9684.8% of flowOrdinary SharesSEC:0000950138-20-000269:0
- 19,396 shares0Ordinary SharesSEC:0000950138-19-000318:1
- 8,527 shares@ US$15.2180.4% of flowOrdinary SharesSEC:0000950138-19-000318:0
- 18,947 shares0Ordinary SharesSEC:0000950138-18-000431:0
- 2,576 shares@ US$15.688.1% of flowOrdinary SharesSEC:0000950138-18-000218:0
- 4,560 shares@ US$21.9420.5% of flowOrdinary SharesSEC:0000950138-17-000770:0Canonical exit: 26 Feb 2018 (T+90)
- 476 shares@ US$37.373.7% of flowOrdinary SharesSEC:0000950138-17-000707:0
25 of 110 declarations
